Skip to content

Efficacy of Attachment-based Compassion Therapy in Population With Chronic Medical Illness (CUIDA-TEC)

Effectiveness of the Internet Attachment-Based Compassion Therapy (iABCT) to Improve the Quality of Life and Well-being in a Population With Chronic Medical Illness.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04809610
Acronym
CUIDA-TEC
Enrollment
68
Registered
2021-03-22
Start date
2021-07-08
Completion date
2023-02-22
Last updated
2021-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Medical Illness

Brief summary

Compassion-Based Interventions are increasingly relevant as a potentially beneficial way to support people with chronic medical conditions and improve different outcomes related with the management of the disease. Online interventions The purpose of this study is to evaluate the effectiveness of the internet version of the attachment-based compassion therapy for improving quality of life in a population with chronic medical illness.

Detailed description

Our participants will be randomized to one of the following two conditions: 1) the Internet version of the attachment-based compassion therapy, and 2) Waiting list (WL) control group. The corresponding evaluations of the outcomes will be carried out at different moments of the process: baseline, and a three- and six-month follow-up. This study will use the internet version of attachment-based compassion therapy (iABCT) for improving the quality of life in a population with chronic medical illness.

Interventions

BEHAVIORALInternet attachment-based compassion therapy (iABCT).

The iABCT is a self-applied program based on the attachment theory and the use of compassion meditations. It is composed of 8 modules that have been reformulated to be completely self-applied and include text, images, illustrations, videos, audio with guided meditations, exercises and homework. Downloadable PDF files will be made available so that users can review them offline. Each module has been optimized to have a duration of 60 and 90 minutes approximately. The entire intervention is estimated to be completed in eight weeks.

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \> 18 years; 2. ability to understand and read Spanish; 3. access to a computer with the Internet; and 4. fulfill criteria for diagnosis of one of the following chronic medical conditions: diabetes, inflammatory bowel disease, fibromyalgia, low-back chronic pain, migraines, and other conditions.

Exclusion criteria

1. Terminal disease; 2. severe psychiatric disorders comorbidities (schizophrenia, substance dependence, bipolar disorder, psychotic illness) or severe neurologic or medical condition; and 3. receiving psychological treatment or mindfulness training at the time of recruitment.

Design outcomes

Primary

MeasureTime frameDescription
Changes in quality of lifeBaseline (week 0), 3-month follow-up, 6-month follow-upEuroQol (EQ-5D; Badia et al., 1999). It is a self-report measures composed by five dimensions of functionality in daily-life and three levels of severity (1-3). A higher score in this scale indicates higher severity on the different areas of functioning in daily life.
Changes in wellbeingBaseline (week 0), 3-month follow-up, 6-month follow-upPemberton Happiness Index (PHI; Hervás and Vázquez, 2013). The scale includes eleven items related to different domains of remembered well-being (general, hedonic, eudaimonic, and social well-being) and ten items related to experienced well-being (i.e., positive and negative emotional events that possibly happened the day before); the sum of these items produces a combined well-being index that range from 0 to 10. Higher levels indicate higher levels of wellbeing.

Secondary

MeasureTime frameDescription
Specific illness interferenceBaseline (week 0), 3-month follow-up, 6-month follow-upSpecific questionnaires will be used to assess specific illness interferences for the different medical conditions included in the study: the Diabetes Distress Scale (DDS; Martin et al., 2007) for participants with type I and type II diabetes; the Roland-Morris Questionnaire (Kovacs et al., 2002) for participants with low-back chronic pain; the Revised Fibromyalgia Impact Questionnaire (FIQR; Salgueiro et al., 2013) for participants with fibromyalgia; the Migraine Disability Assessment questionnaire (MIDAS; Rodríguez-Almagro et al., 2020) for participants with migraines; and the Inflammatory Bowel Disease Questionnaire (IBDQ-32; Masachs et al., 2007) for participants with inflammatory bowel illness.
Self-criticismBaseline (week 0), 3-month follow-up, 6-month follow-upSelf-critical rumination Scale (SCRS; Smart et al., 2016). A 10-item questionnaire measuring self-criticism is defined as a form of negative thinking that devalues the self. It assesses thoughts that criticize the self for perceived errors, failures, weaknesses, defects, bad habits or general inadequacy. It takes into account the ruminative qualities of thought: frequency, duration, repetition, and difficulty of control. Final scores range from 10 to 40 and higher scores indicate a higher level of self-criticism.
SymptomatologyBaseline (week 0), 3-month follow-up, 6-month follow-upThe Depression, Anxiety and Stress Scale (DASS-21; Fonseca-Pedrero et al., 2010). This scale is an abbreviated form of the DASS questionnaire containing 21 items organized in three subscales to assess anxiety, depression, and stress symptomatology. Each subscale has 7 items that range from 0 to 3 points. Higher scores indicate higher levels of symptomatology.
Attachmetn stylesBaseline (week 0), 3-month follow-up, 6-month follow-upThe Relationships Questionnaire (RQ; Yárnoz-Yaben and Comino, 2011). This is a 4-item questionnaire designed to measure adult attachment style. The RQ consists of four paragraphs, each describing an attitude toward relationships in general. The participant rates each paragraph on a scale of 1 (does not describe me at all) to 7 (describes me exactly).
Social supportBaseline (week 0), 3-month follow-up, 6-month follow-upMedical Outcomes Study-Social Support Survey (MOS; Requena et al., 2007). A 20-item questionnaire that analyzes the perception of help and social support. Item 1 refers to the size of the social network and the remaining 19 items measure four dimensions of functional social support: emotional (8 items), instrumental (4 items), positive social interaction (4 items), and affective support (3 items). The items present a 5-point response scale that measures progressively (from never to always) how often each type of social support is available to the caregiver. A total score can also be obtained, where higher scores would indicate more support received.
Compassion and self-compassionBaseline (week 0), 3-month follow-up, 6-month follow-upSussex-Oxford Compassion for the Self Scale (SOCS; Gu et al.,, 2020). This scale asses levels of compassion and self-compassion in a 5-point likert scale. Higher scores indicate higher levels of compassion and self-compassion.
Client's satisfaction3-month follow up (only intervention group), 6-month follow-up (only WL control group)Expectancy and satisfaction questionnaire (adapted from Borkovec and Nau, 1972). A 6-item questionnaire that measures credibility towards treatment and patients' expectations of improvement. Higher score indicates higher levels of client credibility and expectation of improvement.
Difficulties of the compassion practice3-month follow-up (only intervention group), 6-month follow-up (only WL control group)The Compassion Practice Quality Scale (CPQS) (Navarrete et al., 2021) has been developed to assess the key aspects of compassion practices (e.g., mental imagery, sense of connection and warmth, compassionate phrases, and compassionate gestures). This self-reported questionnaire includes 10 items that participants score on a scale ranging from 0 to 100 indicating the percentage of the time that their experience reflects each statement. Higher scores indicate higher quality of practice (i.e., less practice difficulties).
Usability and client acceptance3-month follow-up (only intervention group), 6-month follow-up (only WL control group)System Usability Scale (SUS; adapted from Campos et al., 2020). The System Usability Scale (SUS) provides a reliable tool for measuring the usability of a program. It consists of a 10 item questionnaire with a 5-point likert scale. Higher scores indicate higher levels of usability and client acceptance of the program.
Semi-structured qualitative interview3-month follow-up (only intervention group), 6-month follow-up (only WL control group)An Ad-hoc instrument with open questions created to assess participants' opinions about the program and the support received. Adapted from Campos et al. 2018.
Illness perceptionBaseline (week 0), 3-month follow-up, 6-month follow-upIllness perception questionnaire - revised (IPQ-R; Pacheco-Huergo et al., 2012). The Illness Perception Questionnaire-Revised was designed to assess the cognitive and emotional dimensions of illness representations. The IPQ-R consists of three sections. Two scales measure the identity and causal dimensions and another section assesses the dimensions of duration (acute/chronic), cyclical course, consequences, personal control, treatment control, coherence, and emotional representations.
Self-care and healthy behaviorsBaseline (week 0), 3-month follow-up, 6-month follow-upMindful Self-Care Scale - Brief version (B-MSC; Cook-Cottone, 2018). It is a 24-item scale that measures the frequency of self-care behaviors. The scale addresses 6 domains of self-care: mindful relaxation, physical care, self-compassion and purpose, supportive relationships, supportive structure, and mindfulness. Higher punctuation means a higher frequency of self-care behaviors.

Countries

Spain

Contacts

Primary ContactMaria Angeles Matinez Sanchis
maria.a.martinez-sanchis@uv.es+34963864412

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026